Bambusa Therapeutics

BBTX
16.4101.99% ( +0.320 )
Trading: Nov 16, 11:34:58 (EDT)

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Bambusa Therapeutics(BBTX) the EBIT is -11.27 M (-58.64%);the EPS is -1.98 (--%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B58.64%
----
----
EPS
-1.9789--
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateDec 16, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly